Sunshine Biopharma Inc.

SBFM | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.91

+$0.01 (+1.13%)

At close: Sep 21, 2026, 4:00 PM ET

$0.94

+$0.03 (+3.30%)

After-hours: Sep 21, 2026, 7:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.13%

(1D)

Rating

Updated: Aug 14, 2026

32.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $2.16M

1D Range

0.89 0.97

52W Range

0.82 24.30

Valuation (TTM)

PE -0.09

PB 0.08

EV/EBITDA 2.20

Valuation (NTM)

Forward PE 33.18

Forward PEG 0.00

Price Target $7

Cash Flow

FCF Yield -212.7%

SBC Adj. FCF Yield -212.7%

SBC Impact N/A

Margins

Gross Margin 29.8%

Operating Margin -14.7%

FCF Margin -13.0%

Growth (CAGR)

Revenue 3Y | 5Y 34.5% | 203.1%

Dil EPS 3Y | 5Y 141.7% | 91.0%

FCF 3Y | 5Y 41.7% | -4.5%

Returns

ROA -17.3%

ROE -24.2%

ROIC -18.4%

Financial Health

Net Cash

$13.75M

Current Ratio 5.46

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. ...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 50

IPO Date Feb 14, 2022

Website www.sunshinebiopharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+669.23%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞